This metabolite provides a PDE selectivity profile similar to sildenafil and an in vitro potency for PDE5 roughly fifty% of the dad or mum drug. Plasma concentrations of the metabolite are about 40% of These seen for sildenafil, so that the metabolite accounts for about twenty% of sildenafil’s